PRP – Rational/Indication Does current clinical evidence support the use of PRP for knee OA For which degrees of knee OA is PRP best indicated? Can PRP be used in severe knee OA (KL4)? Is PRP indicated for the treatment of Patellofemoral OA (PFOA)? Are there specific contraindications for the use of PRP for knee… Continue reading ORthoBIologics InitiaTive (ORBIT) Consensus from ESSKA – Section 1
In April 2022, following the annual ESSKA congress, a group of experts published an important document stating their recommendations on the use of PRP in the management of knee osteoarthritis. This is a consensus paper which was obtained after more than 2 years of deliberations on the subject, answering 28 specific questions for which an… Continue reading ORthoBIologics InitiaTive (ORBIT) Consensus from ESSKA
Friday 3rd to Sunday 5th June @ Paris Session program coming soon ! More informations
Monday 23th to Wednesday 25th May C-Symposium: Tuesday 24th May, 12.25 – 13.25 Room 251 RegenPRP/ATS Glue for Diabetic Foot Ulcers & Varicose Leg Ulcers management, evidence-based medicine Dr. Bruno Boezennec, MDDr. Sanaa Benkirane, PhDMs. Sarah Berndt, PhD New Technologies in Wound Care Symposia: Wednesday 25th May, 13.00 – 13.15 Room 202 – 203 A… Continue reading EWMA-CICA 2022
Friday 20th to Saturday 21th May 2022 @ London More informations
Cellular Matrix: Regen PRP-HA combination, next (re)generation Techniques and Protocoles. Friday 13th May, at 16 pm Exclusive Live Training with Dr. Ghislaine Beilin, Specialist in Aesthetic Medicine, Laser and Anti-Aging Medicine (France)
Platelet-Rich Plasma in Female Androgenetic Alopecia: A Comprehensive Systematic Review and Meta-Analysis In this work, Zhou et al.3 summarize different treatment regimes in female androgenetic alopecia (AGA), and quantitively analyze the efficacy of PRP in this disease. They evaluated 636 studies and 12 trials from six databases (MEDLINE, EMBASE, Web of Science, Cochrane Central Register of Controlled… Continue reading Study: Female Androgenetic Alopecia
We welcome you at our booth #03, to share all our latest innovations. The 10 sessions are accessible in replay on the Biobridge Foundation website. For the whole Biobridge program and replay click here.
Platelet-Rich Plasma in The new Medical Devices Regulation (2017/745/EU), applicable since May 2021 in EU, will replace the existing Medical Devices Directives (93/42/EEC). This regulation provides a framework for the manufacture, modification, and use of devices when equivalent devices are not commercially available (Article 5 of the Medical Device Regulation). In these situations, health care… Continue reading New Medical Device Regulation
Platelet concentration is the number of platelets per unit of volume. Usually, platelet concentration is expressed in millions per ml. The platelet concentration factor is the ratio between platelet concentration in PRP and baseline platelet concentration in whole blood and is generally expressed as nX, where n is the value of ratio. When all platelets… Continue reading Platelet concentration & concentration factor
